Catalyst Wire Dossier Catalyst Wire Dossier

Neulastim

Pegfilgrastim · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neulastim, covering 2016-11-21 to 2016-11-21. Get the full timeline:

Most recent: Clinical Trial Update: An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) [Phase 4]

See pricing